TABLE 3. Measures for DAPMT and NDAMPT according to PG-SGA and mortality.
| Death | n | Mean | SD | 95% CI for mean | p | ||
| Yes | DAPMT (mm) | A | 1 | 16.33 | - | ||
| B | 6 | 13.39 | 3.41 | 9.81 - 16.97 | 0.012 | ||
| C | 6 | 8.22 | 1.91 | 6.22 - 10.22 | |||
| NDAPMT (mm) | A | 1 | 13.00 | - | |||
| B | 6 | 12.67 | 3.44 | 9.05 - 16.28 | 0.025 | ||
| C | 6 | 7.56 | 1.96 | 5.50 - 9.62 | |||
| No | DAPMT (mm) | A | 14 | 14.52 | 3.68 | 12.40 - 16.65 | |
| B | 12 | 13.92 | 3.27 | 11.84 - 15.99 | 0.706 | ||
| C | 5 | 13.00 | 3.84 | 8.24 - 17.76 | |||
| NDAPMT (mm) | A | 14 | 15.60 | 8.25 | 10.83 - 20.36 | ||
| B | 12 | 12.94 | 3.51 | 10.72 - 15.17 | 0.475 | ||
| C | 5 | 12.53 | 4.20 | 7.32 - 17.75 | |||
DAPMT=dominant adductor pollicis muscle thickness; NDAPMT=non-dominant adductor pollicis muscle thickness; PG-SGA=patient generated subjective global assessment